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DatabaseNuclear receptors (NRs) are a superfamily of ligand-regulated transcription factors that interact with
coregulators and other transcription factors to direct tissue-speciﬁc programs of gene expression. Recent
years have witnessed a rapid acceleration of the output of high-content data platforms in this ﬁeld, generating
discovery-driven datasets that have collectively described: the organization of the NR superfamily
(phylogenomics); the expression patterns of NRs, coregulators and their target genes (transcriptomics);
ligand- and tissue-speciﬁc functional NR and coregulator sites in DNA (cistromics); the organization of
nuclear receptors and coregulators into higher order complexes (proteomics); and their downstream effects
on homeostasis and metabolism (metabolomics). Signiﬁcant bioinformatics challenges lie ahead both in the
integration of this information into meaningful models of NR and coregulator biology, as well as in the
archiving and communication of datasets to the global nuclear receptor signaling community. While holding
great promise for the ﬁeld, the ascendancy of discovery-driven research in this ﬁeld brings with it a collective
responsibility for researchers, publishers and funding agencies alike to ensure the effective archiving and
management of these data. This review will discuss factors lying behind the increasing impact of discovery-
driven research, examples of high-content datasets and their bioinformatic analysis, as well as a summary of
currently curated web resources in this ﬁeld. This article is part of a Special Issue entitled: Translating nuclear
receptors from health to disease.slating nuclear receptors from
scribed in this review can be
) home page, www.nursa.org.
ll rights reserved.© 2010 Elsevier B.V. All rights reserved.1. Introduction
Nuclear receptors (NRs) comprise a superfamily of conserved
transcription factors (encoded by 48 genes in humans and 49 genes in
the mouse) that are regulated by small lipophilic ligands and cellular
signaling pathways to play essential roles in diverse biological processes
[1]. For example, the estrogen, progesterone and androgen receptors are
important in reproduction, glucocorticoid receptors in glucose metabo-
lism and stress, the thyroid hormone receptor in oxidative metabolism,
andPPARs in lipid and energymetabolism.NRs also encompass one of the
most successful group of targets for drugs currently available, or being
developed, to treat a multitude of therapeutic indices, including
hypertension, cancer, diabetes, cardiovascular disease, cholesterol gall-
stone disease and metabolic syndrome [2–5].
Since the cloning of the ﬁrst NR coactivator, SRC-1/NCOA1, in 1995
[6], intensive characterization has cast coregulators as molecules
required by NRs (and other DNA-binding transcription factors) forefﬁcient regulation of gene expression [7,8]. In contrast to NRs, which
are structurally conserved, their coregulators are diverse, both
structurally and in the way they contribute to the transcriptional
process, namely, through a diverse array of reversible enzymatic
activities such as acetylation, methylation, ubiquitination and phos-
phorylation, or as chromatin remodelers. Given their intercession in
multiple aspects of NR function, including transcription, translation,
splicing and a variety of functional endpoints such as cell motility,
coregulators are essential effectors of the biological activities of NRs
and their ligands.
A recent phenomenon in the NR signaling and other transcrip-
tional ﬁelds is the growing volume of high-content or discovery-driven
datasets whose data points are generated not in pursuit of a speciﬁc
research hypothesis, but rather with the intent of affording broad,
unbiased perspectives on the myriad processes that accompany the
regulation of gene networks in vivo by NRs and coregulators. This
review will begin by discussing the political, cultural and technolog-
ical factors that are shaping the increasing footprint of discovery-
driven research. It will go on to describe the various ﬂavors of high-
content data and the biological processes they inform upon,
illustrating this with examples of insights they have afforded that
would not have readily accrued from focused hypothesis-directed
research. The review will go onto describe how bioinformatic
approaches are being applied to integrate these diverse datasets
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will describe actively curated Internet web resources developed by NR
scientists which complement traditional publication models and help
ensure the unrestricted access of the global NR signaling community
to the results of discovery-driven research.
2. Evolutionofdiscovery-drivenresearch innuclear receptor signaling
While its genomic datasets have been in existence for over a decade,
a number of forces have combined in recent years to drive the
acceleration of discovery-driven research in the nuclear receptor
signaling ﬁeld. Firstly, funding agencies face greater demands from
government for accountability and an increased focus on tangible
beneﬁts of publicly funded research in the form of novel therapeutic
approaches to disease [9]. Accordingly, they are increasingly turning to
collaborative, discovery-driven scientiﬁc consortia to complement and
enhance the research strategies pursued by individual investigators. A
second factor fueling the progress of high-content datasets is the robust
evolution in instrumentation and the increased affordability of
machines that greatly improve on previous generations in capacity,
speed, sensitivity and applicability. Mutliplexed reagents allow for the
interrogation of large numbers of molecular species in space and time
andadvanced labelinganddetection systemscan rapidly and sensitively
discern speciﬁc assaymolecules in complexbiologicalmixtures. Inmany
cases software analysis platforms are integrated into these instruments,
providing for immediate end user analysis of data points. The end result
is that genome-wide, transcriptome-wide and proteome-wide analyses
are increasingly cost effective, providingawealthofdata that, if properly
annotated and archived, will be an invaluable environment for
hypothesis generation and testing for the entire ﬁeld. Indeed such is
their perceived potential to revolutionize biomedical research that high
throughput analysis platforms are candidates for aggressive investment
on the part of the National Institutes of Health [9]. A ﬁnal factor fueling
the evolution of high-content datasets is the growing appreciation by
scientiﬁc publishers of the need to recognize themerits of these studies
as valid and meaningful contributions to scientiﬁc research and as
enduring resources for the wider research community. This will be
discussed in more detail later in this review, but the fact that scientists
can now publish discovery-driven datasets in peer-reviewed journals,
and have these achievements recognized by institutional promotional
committees, augurs well for the future growth and importance of such
resources in the ﬁeld.
3. Categories of discovery-driven research in nuclear receptor and
coregulator signaling
The last decade has seen the evolution of a variety of high-content
platforms, each of which provides information on distinct but inter-
related processes in NR signaling (Fig. 1 and Table 1). These include
phylogenomic and genomic analyses which deﬁned the evolution of
the NR superfamily in distinct species (Fig. 1a); quantitative analysis
of the expression patterns of NRs and coregulators (Fig. 1b); the
deﬁnition of ligand- and tissue-speciﬁc transcriptomes for NRs and
their ligands using expressionmicroarrays (Fig. 1c); cistromic analysis
of functional genomic sites of occupancy of NRs and related
transcription factors (Fig. 1d); proteomics-based spatial organization
of NRs and coregulators into functional higher order complexes, as
well as post-translational modiﬁcation of these proteins (Fig. 1e); and
the application of metabolomics to linking disruption of NR or
coregulator genes in animal models to imbalances in metabolic
intermediates (Fig. 1f).
3.1. Genomics and phylogenomics
The protein sequences of NRs deduced from their cloned cDNAs
had by the late 1980s established the existence of a NR superfamily. Itwas not until the late 1990s, however, that the pioneering bioinfor-
matic milestone in the ﬁeld was reached, namely, the drafting of a
systematic phylogeny and nomenclature for the superfamily, based on
the comparative evolution of the conserved DNA- and ligand-binding
domains of its members [10]. The phylogeny described 6 subfamilies
and 26 groups of receptors; gene names comprised the preﬁx "NR"
followed by an Arabic numeral for the subfamily, a capital letter for
the group and another Arabic numeral for individual genes. The
largest family, family 1, includes the TR, PPAR, RAR, RevERB, ROR and
LXR subfamilies, in addition to FXR, CAR, VDR, PXR. Family 2 includes
the COUP-TF, HNF4 and RXR subfamilies, as well as PNR, TR2 and TR4.
Additional families include family 3, which includes the steroid
receptors (ERs, GR, MR, PR and AR) and the ERR subfamily; family 4
(NURR1, NOR1, NUR77); family 5 (SF-1 and LRH-1); and family 6
(GCNF). In addition, family 0 included receptors containing only one
of the conserved domains, including SHP and DAX1.
Assisted by an almost religious commitment to data archiving, the
intensive, heavily funded genome sequencing efforts of the late 1990s
and early 21st century documented the distribution of genes encoding
NRs in a variety of species, including 48, 49 and 47 in the human [11],
mouse [12] and rat [13] genomes, respectively, 21 in the Drosophila
melanogaster genome [14] and a surprisingly large number (270) in
Caenorhabditis elegans [15]. A comparative genomic analysis of the
human, mouse and rat NR superfamilies found that although a high
degree of sequence conservation existed across species, the variation
was sufﬁcient between somemembers, such as PXR and CAR to suggest
ongoing species-speciﬁc adaptations to environmental factors [13].
These initial discovery-driven surveys ofNR genes in the context of their
cognate genomes laid the groundwork for the rapid accumulation of
data that described their transcriptional and functional biologies.
3.2. Transcriptomics
3.2.1. NR and coregulator target gene transcriptomics
TheNR signalingﬁeld has been extremely active in the production of
expression array datasets – a recent study by NURSA archived nearly
1200 individual datasets across over300unique tissues and cell lines, 91
ligands and 35 NRs [16] which are accessible in the Molecule Pages for
individual NRs and ligands on the NURSA website (see later in this
review for a fuller discussion). Expression arrays, when analyzed using
appropriate statisticalmethods [17], have shown themselves in this and
otherﬁelds to bepowerful tools for linking genome-wideﬂuctuations in
gene expression to speciﬁc signaling inputs and in turn to broader
cellular function. These datasets have emerged largely fromhypothesis-
driven studies focused on individual genes and while they have been
useful as far as those studies have gone, they have been largely under-
utilized as a basis for a database of target genes of NRs and their ligands.
In a ﬁeld which is, at its essence, transcriptional in nature, there is a
glaring need for such a resource and it is hoped that funding agencies
eventually recognize and redress thewide gap in knowledge that exists
in its absence.
3.2.2. NR and coregulator gene transcriptomics
3.2.2.1. Broad strokes: anatomical and circadian proﬁling of nuclear
receptors. Until themid 2000s, NRs as a superfamily had been classiﬁed
solely based on the phylogenomic approach described above [10], but a
pioneering discovery-driven initiative to classify them according to
expression pattern, thereby garnering some insight into their functional
relationships, was undertaken under the auspices of the Nuclear
Receptor Signaling Atlas (NURSA). The NURSA Consortium was the
ﬁrst example in the ﬁeld of a collaborative consortiummodel organized
to generate and distribute to the community a series of inter-related
discovery-driven datasets [18]. The Q-PCR-based study established
anatomical expression proﬁles for the 49 members of the NR
superfamily in 39 tissues from two different strains of the most widely
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approaches to characterizing NR expression patterns were available in
a variety of published reports, they lacked common methodological
platforms and protocols, making meaningful comparisons between
them difﬁcult. The Q-PCR NR expression proﬁling depicted anatomical
NR expression depicting as a circular dendrogram through bioinfor-
matic clustering of the NR tissue expression proﬁle [19]. The dataset
highlighted groups of NRs whose patterns of expression hinted at their
potential to coordinate the transcriptional programs necessary to affect
physiological pathways along twomajor axes: 1) reproduction, develop-
ment, and growth and (2) nutrient uptake, metabolism, and excretion.
[19]. In a parallel study to the anatomical proﬁling, NURSA established for
the community a comprehensive, unbiased and quantitative cartography
of the expression of all NRs over a 24 h cycle in white and brown adipose
tissue, liver, and skeletal muscle [20]. While these studies are tempered
with caveats such as cell-speciﬁc expression of receptors, as well as the
relationship between mRNA and protein, they were nevertheless an
important step towards establishing a framework for hypothesis
generation and testing in the ﬁeld.
3.2.2.2. Filling in the gaps: NR expression in normal physiology and
disease. The two initial NURSAQ-PCRNR proﬁling studieswere the ﬁrst
attempt to deﬁne, on a single technological platform and using a highly
sensitive quantitativemethod, the steady-state expression levels of NRs.
These initial low-resolution passes set the stage for subsequent
discovery-driven efforts pursuing more detailed analyses of NR
expression during development [21] and in the adult endocrine
pancreas [22], bone [23] and brain [24], as well as in two workhorse
cell lines, HepG2 and HeLa [25], providing a valuable resource for the
many researchers using these cell lines. As with the original NURSA
study, these expression proﬁles identiﬁed potential functional relation-
ships between receptors that had not been previously considered.
One of the ﬁrst key follow-up studies [21] to the NURSA study was
one that proﬁled NR expression during development of a higher
organism, namely, the zebraﬁsh Danio rerio, which was chosen since its
transparency during embryogenesis lent itself to systematic whole
mount in situ hybridization.While less amenable to quantiﬁcation than
quantitative PCR, this approach offers the advantage of affording a
perspective on the cellular distribution of NRs within a given organ or
tissue. Charting the spatiotemporal expression 101 NR and coregulator
genes during zebraﬁsh development, this study offered a whole-
organism view of their sites of action, and identiﬁed their potential
functions in central nervous system development. As with a previous
NURSA dataset, tissue-to-tissue ﬂuctuations in the expression of
coregulators were less dramatic relative to NRs. Based on this the
authors asserted that the tissue-speciﬁcity of NR action was due to NRs
rather than coregulators, but this is likely an oversimpliﬁcation given
thewidely acknowledged potential of coregulator complex composition
and post-translational modiﬁcation to inﬂuence the regulation of NR
target genes [26,27]. Extending the embryonic theme into amammalian
setting, a NURSA study proﬁled NR expression in human and mouse
embryonic stem cells and embryoid bodies [28]. The surprisingly large
discrepancy in the expression patterns between the two species of
certain receptors, ERRβ, DAX-1 and LRH-1 in particular, was taken to
indicate distinct species-speciﬁc functions in these cases.
Follow-up studies have been extended to several tissues types,
including the pancreas, in which substantial divergence in expression
of members of the NR superfamily was demonstrated across distinct
cell types [22]. Moreover, this study was extended to evaluate the
relative expression of NRs during hyperglycemia and showed that 16
NRs were signiﬁcantly altered mRNA levels compared to normal
mouse islets. A study in bone provided interesting insights into theFig. 1. Six generations of discovery-driven research in nuclear receptor signaling, 1999–2
coregulator gene transcriptomics, d) cistromics, e) proteomics and f) metabolomics. See tepossible role of NRs in determining the fate of multipotent cell types,
one of which is the calvarial osteoblast, which can follow either an
osteogenic or adipogenic differentiation pathway. The study binned
NRs into one of four expression clusters, namely, those upregulated
during osteogenic, but not adipogenic, differentiation; upregulated in
both conditions, with greater upregulation during adipogenesis;
upregulated equally in both conditions; and downregulated during
adipogenic, but not osteogenic, differentiation [23]. Finally, a Q-PCR-
based brain study demonstrated unambiguous grouping of some NRs
with no previously known functional implication, such as Coup-TFI
and Rev-erbα in a subgroup of brain regions involved in learning and
memory [24]. This type of quantum leap in our understanding of the
role of NRs in normal physiology can only be afforded by large-scale
proﬁling projects of this type, and in concert they establish a solid
rationale for future hypothesis-based research.
A substantial amount of evidence implicates individual NRs as
causative or preventative agents in a variety of disease states, and so a
clear rationale exists to investigate expression patterns across the
superfamily in established models of human disease. Macrophage
activation plays a central role in atherogenesis, autoimmunity, and a
variety of other inﬂammatory diseases. Barish et al. [29] demonstrated
that 28 NRs were expressed in macrophages activated by bacterial
lipopolysaccharide or by interferon-γ, with speciﬁc temporal induction
patterns unique to each stimulus. Extending the analysis to the NCI60
panel of cancer cell lines, a subsequent NURSA study [30] showed that
speciﬁc NR expression patternswere predictive of the drug responses of
individual cell lines, suggesting thatmultiplex proﬁlingofNRexpression
patterns in tumors might afford predictability of the sensitivity of
tumors to speciﬁc NR-based therapeutics.3.3. Proteomics
NR signaling is driven by protein–protein interactions between NRs
and coregulators, as well as between coregulators which associate as
components of large modular complexes [8]. Understanding the
composition of functional NR–coregulator complexes in speciﬁc
signaling contexts could provide a basis for the development of novel
NR- and coregulator-targeted therapeutics. In comparison to expression
arrays and, to a lesser extent Q-PCR, high-content proteomics in the NR
signaling ﬁeld is at a relatively early stage of development. An initial
informatics study [31] combined literature mining with yeast two-
hybrid screening to assemble a database of NR–coregulator interactions.
More recently the NURSA Consortium has devoted considerable
effort documenting the composition of native HeLa cell coregulator
complexes using a combination of afﬁnity puriﬁcation and mass
spectrometry [32]. The immunoprecipitation (IP) / mass spectrometry
(MS) protocol involves cellular fractionation to generate high concen-
trations of protein extracts; (ii) a rapid two-step IP protocol with
reducing stringency of washes; (iii) SDS-PAGE of the immuno-complex
and division of each IP gel lane into 6 regions for sequencing in separate
chromatographic runs [33]. The group has developed a software-based
approach to ﬁltering out non-speciﬁcally binding proteins, which has
been a perennial problem in coimmunoprecipitation. These efforts have
culminated in the recent release of a large dataset documenting 5000
individual coregulator-coregulator interactions (Malovannaya et al., in
press). Although at an early point its development, high-content analysis
of the many post-translational modiﬁcations in NR and coregulator
signal transduction [8] will be an important source of information in
building models for the role of cellular signaling pathways in regulating
the activity of NRs and coregulators.
The NURSA proteomics datasets demonstrate how a discovery-
driven dataset can provide an experimental framework for drawing011: a) Phylogenomics, b) NR and NR ligand target gene transcriptomics, c) NR and
xt for details.
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Table 1
Examples of high-content datasets and associated publications in the nuclear receptor signaling ﬁeld. Literature references for transcriptomics and cistromics of NR and NR ligand
target genes can be found in the Transcriptomics and Cistromics section of speciﬁc Molecule Pages on the NURSA website (www.nursa.org).
System Subsystem Technique Species Tissue/context References
Transcriptomic NRs Q-PCR M. musculus Multiple adult [19]
M. musculus Metabolic circadian [20]
H. sapiens Activated macrophages [29]
M. musculus Adipogenesis in 3T3L1 cells [34]
M. musculus Adult brain [24]
M. musculus Osteoblasts, osteogenesis v adipogenesis [23]
M. musculus Development [21]
M. musculus Adult endocrine pancreas [22]
H. sapiens Cancer cell lines [30]
H. sapiens HeLa and HepG2 cells [25]
M. musculus and H.
sapiens
Embryonic stem cells [59]
Coregulators Q-PCR M. musculus Multiple adult [60]
NR and NR ligand target genes Expression microarray Multiple Multiple See
Legend
Coregulator target genes Expression microarray M. musculus Livers of SRC null mutants [61]
GWLA
(Cistromics)
NR and NR ligand target genes ChIP-chip and ChIP-seq Multiple Multiple See
Legend
Coregulator target genes ChIP-chip and ChIP-seq H. sapiens SRC-3 in 17β-estradiol stimulated
MCF-7 cells
[45]
Proteomic Coregulator-coregulator Afﬁnity puriﬁcation-mass
spectrometry
H. sapiens HeLa cells In Press
YTH/in silico Multiple Multiple [31]
NR–coregulator Afﬁnity puriﬁcation-mass
spectrometry
H. sapiens ERα-SRC-3 in 17β-estradiol stimulated
MCF-7 cells
[45]
Metabolomic NR Mass spectrometry M. musculus NRmodels of diabetes and fatty liver disease
Coregulator Mass spectrometry M. musculus Livers of SRC-2 null mutants [44]
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inferred. Kittler et al. [34] carried out a genome-wide screen for RNA
interference (RNAi) screen for genes important for cell division. Among
other ﬁndings, they identiﬁed a set of transcriptional regulators whose
knockdown resulted in defects in cytokinesis, one of which was SMRT/
NCOR2. Bioinformatic analysis implied a functional interaction between
SMRT/NCOR2, TBL1X and MLL5, an inference the authors were able to
conﬁrmwith reference to the presence of TBL1X andMLL5 in aHeLa cell
SMRT complex from Mitch Lazar's project (10.1621/datasets.01002).
Another study [35] described the cloning and characterization of a novel
coregulator of ERα, CCAR1. Again, the authors leveraged theobservation
of the presence of CCAR1 proteolytic fragments in a TRAP230/MED12
complex characterized by the NURSA proteomics effort [32] to conﬁrm
their own data suggesting that CCAR1 was associated with Mediator
complexes.
3.4. Cistromics and epigenomics
While expression microarrays provide a valuable global perspective
on the collective transcriptional response to a given stimulus, they are
insufﬁcient, in the context of NR-mediated signaling, to implicate the
speciﬁc receptors, coregulators or ancillary transcription factors that
mediate those responses.Moreover they are not designed to distinguish
between directly and indirectly regulated genes, nor the contribution, if
any, of pre-genomic ligand functions to the transcriptional output. The
relatively new discipline of genome-wide location analysis (GWLA)
encompasses a group of techniques which provide data on the speciﬁc
genomic locations ofNRs and coregulators in speciﬁc signaling contexts.
The term “cistromics” was ﬁrst coined by Myles Brown's laboratory –
recognized as the pioneer in the ﬁeld – in the latter part of the last
decade to describe “the complete set of cis-acting targets of a transacting
factor across the genome [36]. Early adopters of GWLA used afﬁnity
puriﬁcationof protein–DNAmixtures (chromatin IP, or ChIP) coupled to
solid phase tiled arrays (ChIP-chip) but this technique has been largely
supplanted by the advent of massively parallel sequencing platforms in
the formof ChIP-seq. The GWLAwaters aremuddied to an extent by thefact that DNA-bound NRs can inﬂuence transcriptional events at
promoters far distant from their sites of occupancy, both proximal and
distal, such that tying transcription of a speciﬁc gene to a speciﬁc DNA-
binding event can for now be done only tentatively. Brown's
groundbreaking papers demonstrated unequivocally that crosstalk on
DNA of ERαwith transcription factors such as FoxA1was an early event
in the regulation of 17β-estradiol/ERα target genes in MCF-7 cells
[37,38] (Fig. 1d). A more recent variant on the GWLA theme is GRO-Seq
(Global Run-On-seq), a deep sequencing approach that acts as a
measure of direct transcriptional output by mapping the location and
orientation of RNA Polymerase II [39]. Lee Kraus’ laboratory has applied
the technique to 17β-estradiol stimulation of MCF-7 cells, opening up
thepossibility of deﬁning the time course of regulation of 17βE2directly
regulated transcripts [40]. In addition to cistromics, a nascent discipline
is epigenomics, namely, the genome-wide study of covalent modiﬁca-
tionsofDNAbyNRs andassociated coregulators, and the impact of these
interactions on tissue-speciﬁc NR-regulated transcriptomes. Initial
studies in this area have cast histones in the role of ﬁne-tuners of NR
binding and suggesting a role for them in tissue-speciﬁc patterns of NR
recruitment to target genes. For example, PPARγ binds preferentially to
genomic regions divested of repressive histone H3 lysine 9 dimethyla-
tion (H3K9me2) and H3K27me3 marks in 3T3-L1 cells undergoing
adipogenesis [41].Moreover, theH3K4me2mark is a keydeterminantof
tissue-speciﬁc binding by FOXA1 and ERα [42] and enrichment of the
histone variant H2A.z is observed in hormone-induced GR-accessible
sites [43]. Future studies will undoubtedly shed further light on the role
of chromatin–NR–coregulator interactions in regulating cell type
speciﬁc expression of NR cistromes.
3.5. Metabolomics
The research output of laboratories such as Bruce Spiegelman,
Ronald Evans, Bert O'Malley and others over the past 20 years has
drawn the ﬁeld inexorably to the realization that both NRs and
coregulators are key players in carbohydrate, fat and lipid metabolism
and, as such, are eminently positioned as therapeutic leverage points
2 URLs for generic bioinformatics resources are as follows: NCBI PubMed: www.ncbi.
nlm.nih.gov/pubmed; NCBI PubChem: http://pubchem.ncbi.nlm.nih.gov; NCBI GEO
www.ncbi.nlm.nih.gov/geo; NCBI OMIM: www.ncbi.nlm.nih.gov/omim; EBI UniProt
www.uniprot.org; NCBI RefSeq: www.ncbi.nlm.nih.gov/refseq; NCBI GenBank: www.
ncbi.nlm.nih.gov/genbank; NCBI UniGene www.ncbi.nlm.nih.gov/unigene; EBI UniProt
http://www.uniprot.org; Pfam: http://pfam.sanger.ac.uk; PDB: www.pdb.org; HUGO:
www.genenames.org; MGI: www.informatics.jax.org; RGD: http://rgd.mcw.edu;
HPRD: www.hprd.org; GAD: http://geneticassociationdb.nih.gov; Phosphosite Plus:
www.phosphosite.org; Molecular Libraries Program: http://mli.nih.gov.
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obesity and the metabolic syndrome. Metabolomics is the systematic
proﬁling of metabolic intermediates involved in biochemical process-
es in cellular systems, and two studies from the NURSA Consortium
illustrate the power of an unbiased metabolomic approach to identify
subtle but critical ﬂuctuations in metabolic intermediates that clarify
the phenotypes of animal models with altered expression of NRs or
coregulators. The ﬁrst demonstrated that knockout of SRC-2/Ncoa2
has a very speciﬁc metabolic phenotype of hypoglycemia and hepatic
overstorage of glycogen, similar to the human genetic disorder type 1
glycogen storage disease or Von Gierke's disease [44]. More recently,
work from the NURSA Consortium has demonstrated that knockout of
SRC-1/Ncoa1 has a more complex metabolic phenotype, involving
impaired gluconeogenesis, decreased glycolytic ﬂux, and compensa-
tory increases in fatty acid and amino acid oxidation (Louet et al. Cell,
in revision, 2009).
3.6. Small molecule modulators
As druggable proteins, NRs and their associated coregulators are
therapeutic targets in awide variety of diseases anddisorders.WhileNR
modulator-based research platforms are well established in private
pharmaceutical companies, notably GlaxoSmithKline, Johnson & John-
son, Wyeth Pharmaceuticals and others, the ﬁeld to date has lacked a
public discovery-driven effort to generate small molecule modulators
and ligands for the use of the research community. Similarly, while for-
fee access databases such as that of the American Chemical Society are
comprehensive, public resources such as NCBI PubChem remain in a
developmental stage – ligands for speciﬁc NRs are not yet linked to
records for those receptors inNCBI Entrez, for example. A recent effort to
redress this imbalance and provide the broader research community
with a high throughput screening service is the Molecular Libraries
Program (MLP). The goal of theMLP is to provide researcherswithwhat
would otherwise be the prohibitively expensive chemistry, screening
and informatics support required to probe the role of small molecule
modulators in cellular pathways.
4. The role of bioinformatics
At its essence, bioinformatics complements discovery-driven re-
search efforts by (i) developing computational and mathematical
approaches to detect statistically signiﬁcant patterns and trends across
complex and diverse discovery-driven datasets; and (ii) developing
web applications designed to facilitate the annotation, widespread
accessibility and enduring availability of these datasets to a userbase of
technologically diverse biologists. In this section I will provide a recent
example of an integrative analysis of high-content datasets, as well as
discussing currently curated web resources of relevance to this ﬁeld.
4.1. Bioinformatics challenge I: Integrative analysis of discovery-driven
datasets
An important bioinformatic goal is the successful integration of the
myriad types of high-content data depicted in Fig. 1 with the goal of
developing reliable paradigms forNR signaling,withinwhich the posing
and testing of hypotheses might take place. In a landmark study Lanz et
al. established a paradigm for how bench transcriptomics, cistromics
andproteomics couldbemarriedby integrativebioinformatics in awell-
established model for NR action, namely, 17β-estradiol stimulation of
MCF-7 cells [45]. In doing so, they framed a working model for how
functional interactions between activated NRs, coregulators and DNA
give rise to efﬁcient regulation of gene networks in vivo. The ﬁrst
component of the analysis was an afﬁnity puriﬁcation/mass spectro-
metric analysis of ERα and SRC-3-associated proteins in MCF-7 cells
treated with 17βE2. The second component was a previous study from
NURSA, namely, the GEMS 17βE2/MCF-7 expression microarray meta-analysis dataset [46], which drew upon the combined statistical power
of multiple aligned microarray experiments to establish a consensus
transcriptional response in this system. The ﬁnal components were an
SRC-3/NCOA3 GWLA analysis in 17βE2-treated MCF-7 cells, in addition
to previously published GWLA experiments in the same model system
[38]. The increased conﬁdence resulting from integrating multiple
experimental approaches allowed the group to paint ontology annota-
tions onto the 17βE2 transcriptome and common ERα/SRC-3 ChIP
binding signatures, effectively correlating the system's endpoint biology
with promoter occupancy. While conﬁrming previously characterized
functions of SRC-3 on 17βE2 target genes (TFF1, XBP1), this analysis also
identiﬁed SRC-3 and ERα binding on previously unrecognized ERα
targets such as ERBB2. Moreover, the unbiased approach identiﬁed an
anticipatedhighdegree of convergencebetweenERα andSRC-3binding
sites in addition to signiﬁcant overlap between SRC-3 and FoxA1which
was taken to represent an unexpected convergence in the biology of
these proteins [45].
4.2. Bioinformatics challenge II: Archiving and communicating discovery-
driven research
Since the mid 19th century, the peer-reviewed primary research
article that establishes a hypothesis, describes themethods, reports the
results of the experiments and interprets their signiﬁcance, has been the
mainstay of scientiﬁc communication. While printed journals were
adequately scoped to accommodate the discrete, circumscribed content
these articles contained, they were never designed to communicate the
high-content datasets this review has discussed. Expression micro-
arrays, for example, demonstrate the glaring lack of infrastructure in
place in journals, even those on advanced electronic publishing
platforms, to effectively accommodate high-content datasets. The
expedient in this case has been that due to printed page constraints,
the authors select a handful of genes that show signiﬁcant regulation –
the so-called gene list – and communicate those in the paper. The actual
array data, if available at all, appears often as a ﬂat PDF in supplemental
materials, and even rarer still, is submitted to a publically accessible
database. This situation is unsatisfactory at best, leaving the vast
majority of expression array data not only unreported, but refractory to
further analysis by other investigators [47].
The opacity of the traditional research article to datamining, and the
rapid evolution in Internet technologies that provide for rich, intuitive
user experiences in websites, have driven the evolution of a new
generation of biological databases inwhich a ﬁrm emphasis is placed on
usability, that is, the interface between the human researcher and the
biological data. Many of these sites – NCBI (National Center for
Biotechnology Information) PubMed,2 NCBI PubChem, NCBI GEO
(Gene Expression Omnibus) and EBI UniProt to name a few – are
generic, broad spectrum resources with whole genome coverage. In
addition to these, the NR and coregulator ﬁeld has a number of actively
curated, freely accessible specialist databases (Table 2).
4.2.1. NURSA
The Molecule Pages of the NURSA website have evolved since their
launch in 2003 into a portal which encompasses a broad variety of
biological resources of relevance to NRs, their ligands, coregulators and
target genes, both from datasets generated as part of the NURSA
Table 2
Web and bioinformatics resources in the nuclear receptor signaling ﬁeld. Note that only
currently curated, unrestricted access sites are listedhere.Manyother databases existed at
one time but are either no longer actively curated or available on the Internet. URLs:
NURSA, www.nursa.org; Nuclear Receptor Resource, http://nrresource.org/; IUPHAR,
http://www.iuphar-db.org/DATABASE/ReceptorFamiliesForward?type=NHR; Androgen
Receptor Mutation Database http://androgendb.mcgill.ca/; Androgen-Responsive Gene
Database, http://argdb.fudan.edu.cn.
Database Curated information and
data1
Origin
NURSA Q-PCR expression of
nuclear receptors
NURSA
www.nursa.org
Afﬁnity puriﬁcation/
Mass spectrometry of
coregulator complexes
NURSA
Expression microarrays
of NR target genes
NURSA
ChIP-seq of NR cistromes NURSA
NR and CoR interactions NURSA, Entrez
Gene
Ortholog information Various
NR ligands NCBI
PubChem
NR and NR ligand
transcriptomes and
cistromes
NCBI PubMed,
GEO
NR and CoR pathology NCBI PubMed
OMIM Morbid
Map
HPRD, GAD
NR and CoR animal
model phenotypes
Jackson
Laboratory
Literature NCBI PubMed,
Molecular
Endocrinology
Educational Resources NURSA
Nuclear Receptor Resource Pathways NRR
http://nrresource.org Educational Resources NRR
Expression NURSA
IUPHAR Ortholog information Various
http://www.iuphar-db.org/DATABASE/
ReceptorFamiliesForward?
type=NHR
Ligands IUPHAR
NR and CoR Interactions NCBI PubMed
Target Genes NCBI PubMed
Animal models NCBI PubMed
Androgen Receptor
Mutation Database
Androgen receptor gene
mutations
NCBI PubMed
http://androgendb.mcgill.ca/ Androgen receptor-
interacting proteins
NCBI PubMed
Androgen-Responsive Gene Database
http://argdb.fudan.edu.cn
Androgen and androgen
receptor target genes
NCBI PubMed
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pages include links to cDNA and genomic DNA sequence repositories
such as the NCBI database collection (including NCBI RefSeq, GenBank
and UniGene); protein sequence repositories such as the UniProt/EBI-
databases SwissProt, Pfam and the protein structural and crystallo-
graphic database PDB; portals for species-speciﬁc gene collections such
as HUGO (human), MGI (for mouse data), RGD (rat); gene expression
resources (NCBI GEO, MousePAT, Allen Brain Atlas); reciprocal links
with specialist resources such as the FAST-DB transcript and splicing
resource and the Phosphosite Plus post-translational protein modiﬁca-
tion resource; and NCBI's literature resource, NCBI PubMed. NURSA has
engaged members of both the academic and industrial communities in
developing its NR ligand database, which integrates information from
resources such as NCBI PubChem and PDB on nearly 250 NR ligands.
Other content includes a Diseases and Phenotypes module which
integrates curated, literature-based information on the disease involve-
ment and animal model phenotypes of NRs and coregulators from
generic resources such as OMIM, HPRD, GAD (Table 2). An Interactions
module combines literature-based information on the protein–proteininteractions of NRs and coregulators from NCBI, as well as coregulator
proteomicsdata generatedbyNURSA (Fig. 1e). Themost recent addition
is a Transcriptomics and Cistromics module, which catalogs published
expression microarray and GWLA studies related to NRs and their
ligands and annotates them for tissue or cell line and species of study
[16].
The website also has an electronic publishing alliance with the
premier specialist research journal in the ﬁeld,Molecular Endocrinology,
through which reciprocal links are established between journal articles
and related Molecule Pages on the NURSA website. These annotations
provide article readers with one-click access to contextual information,
and NURSA website users with targeted content from a respected
journal in the NR signaling ﬁeld.
4.2.2. IUPHAR
The International Union of Basic and Clinical Pharmacology
(IUPHAR), formerly the International Union of Pharmacology, was
established in1959as a forum for scientists in a variety of pharmacology-
related ﬁelds, including NRs, G-protein coupled receptors and others.
IUPHAR has taken a leading role in establishing nomenclatures for gene
families and regularly solicits reviews from leading investigators in
speciﬁcﬁelds to summarize recent research [48,49]. IUPHARhas recently
undertaken an initiative to migrate expert-curated content from its
reviews into relational databases, and to establish links with other
generic and specialist resources to provide contextual information for its
userbase. The IUPHAR database on NRs (Table 2) provides information
on NR orthologs, ligands, interactions, target genes and animal models
that was originally published in a series of reviews on the NR ﬁeld. As a
specialist pharmacology resource, IUPHAR is uniquely placed to provide
expert curation in the area of NR ligands, and it is hoped that future
versions of the databasewill continue to add to its content in this area for
the beneﬁt of users of this and other databases in the ﬁeld.
4.2.3. Nuclear receptor resource
The Nuclear Receptor Resource was the ﬁrst presence for the NR
community on the Internet and included several interconnected but
distinct web resources focused on difference receptors or receptor
subfamilies [50], see also below. Several of the sites are unfortunately no
longer actively curated and those that remain have been consolidated
into a single resource that provides educational resources, information
onNR-regulated pathways, NR interactions andNRexpression patterns,
reproduced from the original NURSA expression studies [19,20] (see
Table 2 for URL). The site also links to a tool for searching for PPAR
response elements in any given genomic DNA sequence.
4.2.4. Androgen receptor mutations database
This well-established resource, launched in 1998 and updated
monthly, documents published and unpublished somatic mutations
and polymorphisms in the human AR gene in a variety of diseases,
including prostate cancer and diseases associatedwith CAG tract length
variations. It also includes a list of AR-interacting proteins curated from
the published literature (see Table 2 for URL).
4.2.5. Androgen-responsive gene database
This web resource is based on intensive curation of the published
literature toassemble adatabase of a total of 3300human,mouseand rat
androgen-regulated genes, alongwith essential hand-curatedmetadata
such as expression fold change, androgen-responsive sequence (where
available), response time, tissue/cell type, experimental method, and
ligand identity and concentration. The database is integrated with
multiple external resources, including NCBI, Gene Ontology, and Kyoto
Encyclopedia of Genes and Genomes, to afford the user convenient
access to information on the biological characteristics and context of
androgen-regulated genes (see Table 2 for URL).
In addition to these active bioinformatic resources, many useful
databases existed at one time but have since gone ofﬂine or are no
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These include NUREBASE [51], NucleaRDB [52], NRSAS [53], NRMD [54],
ERGDB [55], ERTargetDB [56] and KBERG [57]. Some of the earliest
efforts to establish a presence on the Internet for the NR signaling
community occurred under the auspices of the Nuclear Receptor
Resource [50], and included Mark Danielsen's Glucocorticoid Receptor
Resource and David Moore's Thyroid Receptor Resource, both of which
are now defunct. The loss of the time and effort that were in invested in
collecting, curating andmaintaining these and other databases is highly
regrettable, and there is a glaring need for funding agencies worldwide
to recognize the value to the research community of continuing
investing in web-based resources in this ﬁeld in order to ensure their
ongoing curation. Conceivably, funding could bemade available, at least
for American resources, through the US National Library of Medicine to
maintain and ensure the continued curation of some of the larger
resources for posterity.
5. Concluding remarks
Supported by an increasingly sophisticated data gathering analysis
and distribution infrastructure, discovery-driven research has made
tangible progress over the last decade or so in deconstructing the
baroque biology of NRs and their coregulators. The next challenge at the
bench level is one of resolution: to date, most large-scale data
acquisitions have been at the level of the tissue or organ, glossing over
issues such as the cell- and promoter-speciﬁcity of NR and coregulator
function. Single cell- and organelle-level analyses will provide valuable
information on the subcellular dynamics of NRs and coregulators, the
function of splice forms of these factors, and the role of speciﬁc post-
translational modiﬁcations in ﬁne-tuning their modes of action.
Extrapolating these observations to ﬂuctuations in single-cell metabo-
lomes will conceivably provide for more accurate information on the
relationship between ligands, NRs, coregulators and homeostatic
control at the cellular level. Finally, deﬁning the relationship at the
single cell level between these factors and the regulation of cell division
and motility will undoubtedly expose leverage points for therapeutic
intervention in the myriad neoplastic diseases in which they are
implicated. Gathering, archiving and analyzing these data in an
integrated fashionwill be a tremendous experimental andbioinformatic
challenge, but the payoff in terms of more focused, efﬁcient and cost-
effective therapies, is likely to be commensurate.
Despite its size and demonstrable relevance to health and disease,
however, the ﬁeld of NR signaling has a relatively small number of
specialist, publically available web and bioinformatic resources. Given
the number of established journals in theﬁeld this has until recent years
not been a pressing concern, but the growing number and diversity of
high-content technological platforms indicates that dataset archiving,
analysis and distribution will become critical elements of future
scientiﬁc progress in this ﬁeld. The daunting volume of data points
that will be generated by these and other initiatives over the next
decade warrants a committed effort on the part of researchers, funding
agencies and publishers to ensure that the bioinformatic infrastructure
is in place to ensure the effective management of these data resources,
and that data mining does not develop into a bottleneck to restrict
progress in the ﬁeld.
While this review has to date focused on NR and coregulator
signaling-speciﬁc resources, their multifaceted roles in physiology and
disease argues strongly for existing and future bioinformatics efforts to
engage resources in parallel disciplines with a view to sharing database
resources for the mutual beneﬁt of their respective user bases. Consider,
for example, a clinician searching a diabetes-focused database who is
empowered to view expression of NRs and coregulators in the diabetic
endocrine pancreas, or a NR scientist who is able to tap into cancer gene
expression data from another database, ﬁltered by NR or coregulator
Gene IDs. The synergy that arises from the intersection of the data in
distinct databases in these and other instances can be readilyappreciated, and the incipientefforts of theNational Institute ofDiabetes,
Digestive and Kidney Diseases in establishing dkCOIN [58] bodes well in
this regard. This network of databases is being developed to establish
interconnectivity between molecule-, disease- and organ- and mouse
model-centric databases to provide clinicians and scientists with access
to data resources beyond their own sphere of research or interest.
The full value of high-content datasetswill be realized onlywith their
full unrestricted availability, and it is incumbent on the community to
ensure they are archived and annotated with the same alacrity as were
DNA sequences in the 1980s and 1990s. Unlike sequence data, these
datasets are highly contextual in nature and must be associated with
detailed critical metadata that articulate these contexts. Without a
commitment on the part of funding agencies to funding andmaintaining
databases curated by experts in the ﬁeld, there can be little doubt that
much of it will be lost to posterity. Equally, if publishers do not apply
rigorous standard to the deposition of high-content datasets in
appropriate public repositories, much of it will never reach the public
domain, as has regrettably been the case for expression array datasets
[47]. If these goals can be achieved however, discovery-driven research
and bioinformatics will undoubtedly form the foundation of signiﬁcant
strides in our understanding of NR and coregulator biology in the next
decade and beyond.
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